Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD
Contact our Ozempic attorneys immediately for a free case evaluation to protect your legal rights and understand your specific timeline
Obesity Reviews.
Beyond semaglutide, other innovative GLP-1 receptor agonist medications, such as Tirzepatide , which is also a GIP receptor agonist, are available and FDA-approved for once-weekly administration under brand names like Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
At Maven Clinic, our expert clinicians will help you choose between oral and injectable forms based on your health history, goals, and stage of life